Calgary, Alberta – TheNewswire - October 14, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that it is holding a webinar to discuss the one-month patient results for its initial Group 1 patients that received the Ocumetics Accommodating Intraocular Lens (the “Ocumetics Lens”). Webinar details are as follows: Date: Thursday, October 15, 2025Time: 6:00 PM ET Join Ocumetics Director ...

 Calgary, Alberta – TheNewswire - October 8, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to report encouraging one-month safety and vision performance results for the first Group 1 patients that received the Ocumetics Accommodating Intraocular Lens (the “Ocumetics Lens”). “This again is a historic milestone for Ocumetics and for ophthalmology as a whole,” said Dean Burns, President and CEO of ...

Calgary, Alberta – TheNewswire - September 26, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that the Company successfully completed its second surgical day in Mexico City as part of its ongoing clinical study evaluating the Ocumetics Accommodating Intraocular Lens (the “Ocumetics Lens”).All procedures were completed safely and without any reported issues or complications. These res ...

   Calgary, Alberta – TheNewswire - September 16, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is excited to announce that it has completed one-month postoperative examinations of the first patients who were implanted with the Ocumetics Accommodating Intraocular Lens in Mexico City on August 15, 2025 (the “Ocumetics Lens”).   “On Friday September 12th, we performed one-month postoperative examinations of ...

Core Insights - Ocumetics Technology Corp. has successfully completed the one-week postoperative examination of the first patients implanted with the Ocumetics Accommodating Intraocular Lens, with all patients recovering well and no complications observed [1][3] - The company is now recruiting additional individuals to complete the first group of patients for the Ocumetics Lens [2] - The Ocumetics Lens aims to redefine vision correction by allowing the eye's natural muscular activity to focus on both distant and near objects without the need for glasses or contact lenses after cataract surgery [3][5] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions to enhance patients' quality of life [4] - The company is dedicated to transforming the field of ophthalmology through innovative research and development of state-of-the-art intraocular lenses and other vision-enhancing technologies [4] Product Development - The Ocumetics Lens is designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses by providing clear vision at all distances [5] - The company is currently in the preclinical study phase for this groundbreaking technology in the ophthalmic industry [5]